MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan

MaineHealth 癌症护理网络 (MHCCN) 和 NCORP 整个生命周期的活动

• 批准号: 10224139
• 负责人: Leslie Bradford
• 金额: $ 83.75万
• 依托单位: MAINEHEALTH
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-08-13 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10224139
• 关键词: Academic Medical Centers; Adolescent and Young Adult; Adult; Award; Cancer Burden; Cancer Center; Cancer Control; Cancer Control Research; Cancer Model; Cancer Patient; Caring; Cause of Death; Child; Childhood; Clinical; Clinical Research; Clinical Trials; Clinical Trials Network; Communities; Community Care Networks; Community Clinical Oncology Program; Complex; Consensus; Denmark; Diagnosis; Elderly; Enrollment; Ensure; Environmental Exposure; Evaluation; Evolution; Face; Family; Fostering; Genomics; Geography; Goals; Grant; Growth; Health Personnel; Health system; Healthcare; Healthcare Systems; High Prevalence; Home; Hospitals; Human papilloma virus infection; Incidence; Infrastructure; Intervention; Investments; Lead; Leadership; Location; Longevity; Maine; Malignant Childhood Neoplasm; Malignant Neoplasms; Medical; Mission; Morbidity - disease rate; New England; Obesity; Occupational; Oncology; Operative Surgical Procedures; Outcome; Outcomes Research; Participant; Patient-Centered Care; Patients; Personal Satisfaction; Population; Prevention; Prevention Research; Process; Provider; Quality of life; Radiation; Radon; Reporting; Research; Research Design; Research Personnel; Resources; Risk Behaviors; Rural; Rural Community; Spain; Specialist; Strategic Planning; Sun Exposure; System; Testing; Therapeutic; Time; Translational Research; anticancer research; base; cancer care; cancer clinical trial; cancer genomics; cancer health disparity; cancer prevention; cancer risk; care delivery; career development; cigarette smoking; community engagement; community setting; early phase trial; end of life; expectation; health disparity; improved; inhibitor/antagonist; interdisciplinary approach; member; metropolitan; mortality; next generation; oncology program; outpatient facility; patient oriented; public health relevance; research study; response; rural area; rural cancer care; rural setting; screening; socioeconomics; survivorship

Abstract Maine ranks 12th and 8th in adult cancer incidence and mortality respectively, and pediatric cancer incidence rates are the third highest in the nation, contributing to marked cancer health disparities in our state. In 2018, it is estimated there will be 8,600 new adult cancer cases diagnosed in Maine; cancer is the most common cause of death in our state. Of these adult cases, 6,185 (72%) will receive their care at a MaineHealth Cancer Care Network (MHCCN) hospital or outpatient facility. This patient volume is akin to any major metropolitan cancer center. With only 1.3 million residents, Maine is a small state, is the most rural state, and has the oldest population in the nation. There are significant cancer risk behaviors and exposures, and there are numerous socioeconomic and geographic challenges as well, further compounding our cancer burden. The MHCCN is clearly organized around patient, health provider, and healthcare system multi-tiered strategies and interventions that are prioritized in the NCORP solicitation and defended in this proposal. Our health system embarked upon a comprehensive oncology strategic planning process in 2014 that in a relatively short period has led to the opportunity to submit our response to this FOA. Consensus was reached on the model of cancer care that we would pursue. The singular goal is to ensure that "the right care, in the right location, as close to home as possible" will be provided. Cancer patients in our state and their families desire access to state-of-the-art patient-centered care. This NCORP application could not come at a more auspicious time for our organization, coinciding with significant growth and substantive multi- million dollar investment in MH Oncology over the past couple years. With this backdrop, the fundamental goal of our application is to commit and contribute to a robust slate of NCORP activities across the lifespan including pediatric, adolescent and young adults, adults, and elderly cancer patients in our communities and rural care settings. We have assembled a highly interactive and interdisciplinary team across our network to participate in and lead this research endeavor. Our central hypothesis is that developing a highly interactive and interdisciplinary approach to cancer care that is at all times patient-centered throughout MH Oncology will have salutary effects on all aspects of our cancer care across the continuum of prevention, screening, diagnosis, treatment, survivorship, end-of-life, and care delivery not only for our patients and their families but for other aspects critical to our mission – including educating the next generation of healthcare providers and expanding our research pursuits especially in rural areas within our care network. We propose 4 aims: To conduct and actively participate in 1) cancer control research, 2) cancer prevention research, and 3) cancer care delivery research studies; and 4) to capitalize upon clinical research opportunities afforded by NCORP and our newly awarded Northern New England Clinical and Translational Research Network grant (1U54 GM115517). We will pursue these aims across the lifespan engaging both children and adults. The MHCNN has every expectation that will we make substantive contributions across the spectrum of the NCORP research portfolio. We will capitalize on our institutional assets, patient resources, and expertise from the vantage point of community and rural settings to add value across the lifespan and provide leadership to the NCORP. We welcome and value the opportunity to join the NCORP network as a new institutional member.

抽象的 缅因州的成人癌症发病率和死亡率分别排名第12和第八，小儿癌发病率是第三 在全国最高，为我们州的癌症健康分配做出了明显的贡献。 2018年估计将有8,600个新成人 在缅因州诊断出的癌症病例；癌症是我们州最常见的死亡原因。在这些成人案件中，有6,185（72％）将 在Mainehealth癌症护理网络（MHCCN）医院或门诊设施中获得护理。该患者体积类似于任何 大都市癌症中心。缅因州只有130万居民，是一个小州，是最粗糙的状态，并且最古老 全国人口。有巨大的癌症风险行为和暴露，并且有许多社会经济和 地理挑战也进一步加剧了我们的癌症伯恩。 MHCCN显然是围绕患者，健康组织的 提供者和医疗保健系统多层策略和干预措施在NCORP招标中优先考虑并进行辩护 这个建议。我们的卫生系统在2014年开始了全面的肿瘤学战略计划过程 时期使我们有机会提交我们对此FOA的回应。就癌症护理模型达成了共识 会追求。一个单一的目标是确保“在正确的位置，尽可能靠近家中的正确护理”将是 假如。我们州及其家人的癌症患者希望获得以患者为中心的最先进的护理。这个ncorp 对于我们的组织而言，应用程序无法在更吉祥的时期来到 过去几年，对MH肿瘤学的百万美元投资。在这种背景下，我们应用的基本目标是 在整个生命周期中施加并促进了包括儿科，青少年和年轻人的强大的NCORP活动， 我们社区和粗糙护理环境中的成年人和年长的癌症患者。我们组装了一个高度互动的， 跨学科团队跨我们的网络参与并领导这项研究努力。我们的中心假设是发展 一种高度互动和跨学科的癌症护理方法，始终以患者为中心的MH肿瘤学有 在预防，筛查，诊断，治疗，生存期间，对我们癌症护理各个方面的有益影响 寿命末和护理不仅适合我们的患者及其家人，而且对我们的使命至关重要的其他方面 - 包括 教育下一代医疗保健提供者并扩大我们的研究追求，尤其是在我们护理中的农村地区 网络。我们提出4个目标：进行和积极参与1）癌症控制研究，2）预防癌症研究和3） 癌症护理提供研究； 4）利用NCORP和我们新的临床研究机会 授予北部新英格兰临床和转化研究网络赠款（1U54 GM115517）。我们将追求这些目标 在整个生命周期中都吸引了儿童和成人。 MHCNN有一切期望，我们将做出实质性贡献 跨越NCORP研究组合的范围。我们将利用我们的机构资产，患者资源和专业知识 从社区和粗糙环境的有利位置，可以在整个寿命中增加价值，并为NCORP提供领导。我们 欢迎并重视成为新机构成员加入NCORP网络的机会。